Summary of findings table ‐ Continuation vs reduction of polypharmacy
Adverse effects: ≥ 1 adverse effect – total · patients with schizophrenia
It is very uncertain whether summary of findings table ‐ Continuation changes adverse effects: ≥ 1 adverse effect – total compared with reduction of polypharmacy (very low certainty).
1 finding from 1 review
- Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia 2022 · Cochrane Headline outcomes onlyRR 5 [0.28, 88.53]1 study · 14 participantsVery low